This post is available for a fixed term of 6 months with the possibility of extension dependent on funding.

The major role will be to dissect the molecular pathways underpinning the pathology of Scleroderma with the aim to identify therapeutic targets for future intervention development.

The post is key to the success of research projects in various areas of connective tissue disease, focusing particularly on Scleroderma. Responsible to Dr Del Galdo, you will continue and develop research in identifying therapeutic targets suitable of intervention and studying the molecular pathways underpinning connective tissue diseases. Research qualified, early post PhD, with publication track record in the immunologic aspects of Scleroderma, you will be a highly motivated team player with highly effective interpersonal and communication skills and the ability to conduct high quality basic research and deliver outcomes to challenging deadlines

The University of Leeds is committed to providing equal opportunities for all and offers a range of family friendly policies (http://hr.leeds.ac.uk/homepage/4/policies). The University is a charter member of Athena SWAN and holds the Bronze award. The School of Medicine gained the Bronze award in 2013. We are committed to being an inclusive medical school that values all staff, and we are happy to consider job share applications and requests for flexible working arrangements from our employees.

University Grade 7 (£30,728 – £36,661) depending on qualifications and experience

Informal enquiries regarding the post should be directed to (Dr Francesco Del Galdo, f.delgaldo@leeds.ac.uk)

If you have any specific enquiries about your online application please contact (Gayle Iype, +44 (0) 113 3924884, g.a.iype@leeds.ac.uk)

Closing Date: 19 May 2014